Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Convalescent Plasma for Patients Hospitalized With COVID-19 Disease

NCT04385199 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04385199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Convalescent Plasma for Patients Hospitalized With COVID-19 Disease
Lead sponsor
Henry Ford Health System
Phase
Phase 2
Overall status
Completed
Start date
May 4, 2020
Completion date
August 1, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, coronavirus infection, covid